Zantac

See if you qualify today! 

Were you diagnosed with cancer?

SEE IF YOU ARE ELIGIBLE FOR A Zantac Cancer CLAIM

Step 1 of 11

Did you or a loved one take Zantac (Zantac, Zantac75, Zantac 150, Zantac Extra Strength) for a minimum of 1 year?(Required)
Are You At Risk?

Zantac Lawsuits

In April 2020, the FDA ordered the removal of all Zantac (ranitidine) products from the market. This decision was made due to concerns about the presence of N-Nitrosodimethylamine (NDMA), a human carcinogen, which could form in ranitidine products over time and when exposed to heat.

NDMA present in Zantac could lead to various types of cancer, including but not limited to:

  • Bladder
  • Breast
  • Colorectal
  • Esophageal
  • Gastric/Stomach (No Intestinal)
  • Kidney
  • Liver
  • Pancreatic
  • Prostate


If you used Zantac, Zantac75, Zantac 150, or Zantac Extra Strength for at least one year, and already have been diagnosed with cancer, you could be eligible for significant compensation.

Background.

What is Zantac?

Zantac, the brand name for ranitidine, is a medication used to reduce stomach acid production. People take Zantac to treat and prevent heartburn, gastroesophageal reflux disease (GERD), and stomach ulcers. The Zantac lawsuits are about allegations that the drug contained a human carcinogen called N-Nitrosodimethylamine (NDMA). NDMA is classified as a probable carcinogen by the International Agency for Research on Cancer.

Chemical Breakdown.

Poisonous Aftermath

Zantac (ranitidine) has been owned and marketed by various pharmaceutical companies over the years. Here are the key owners and marketers of Zantac:

GlaxoSmithKline (GSK): Zantac was developed and first marketed by GSK after its discovery in the 1970s. It became a major blockbuster drug for the company.

Pfizer: In 2000, Pfizer acquired the over-the-counter (OTC) rights to Zantac from GSK. Pfizer marketed Zantac OTC for a period of time.

Boehringer Ingelheim: In 2006, Boehringer Ingelheim acquired the rights to market Zantac OTC from Pfizer.

Sanofi: In 2017, Sanofi acquired the rights to market and sell Zantac OTC from Boehringer Ingelheim. Sanofi was responsible for the drug at the time the NDMA contamination concerns became widely known.

Stay Up To Date.

Latest Updates

Most recently in May 2024, Sanofi agreed to pay between $200 million and $250 million to settle more than 10,000 Zantac lawsuits. This came after Sanofi separately offered to pay $100 million to settle 4,000 Zantac lawsuits in April 2024. GlaxoSmithKline also settled multiple cases confidentially early in 2024. In May 2024, the Financial Times reported Pfizer offered up to $250 million to settle 10,000 cases.

Still Have Questions?

We're Here to Help You

Navigating afff/pfas claims can feel daunting, but you don’t have to face litigation alone. Here are the answers to commonly asked questions about filing a afff/pfas lawsuit.

If you used Zantac, Zantac75, Zantac 150, or Zantac Extra Strength for at least one year, and have been diagnosed with cancer by a Doctor, you could be eligible to participate in the lawsuit against the drug's manufacturers.

Thousands of cases are already in front of Judges around the country. Many of these cases have been consolidated into multidistrict litigation (MDL) to streamline the process and handle the numerous claims more efficiently. This allows for coordinated pretrial proceedings and discovery.

If you have cancer after using Zantac for a prolonged period, it's crucial to get involved in the lawsuit as early as possible, as thousands of cases have already been submitted nationwide. Please fill out your information on our website so you can be contacted by a case expert to explain your options.

Still Have Questions?

Helpful Resources & Articles

Mounjaro Interactions: Alcohol, Medications, and More

Mounjaro Interactions: Alcohol, Medications, and More

Mounjaro is a weekly injectable drug used to treat type 2 diabetes through improved blood…

Zepbound: Uses, Side Effects, and More

Zepbound: Uses, Side Effects, and More

In November 2023, the Food and Drug Administration (FDA) approved Zepbound, a tirzepatide injection, for…

Rybelsus Side Effects and Risk Factors

Rybelsus Side Effects and Risk Factors

Rybelsus is the brand name for an oral semaglutide tablet. Semaglutide is a glucagon-like peptide-1…

Empowering your legal journey in mass tort claims. Advocacy and justice await.

Newsletter

Subscribe our newsletter to get our latest update & news

Tort Defenders - Copyright 2024 © All Right Reserved